Expanded HIV screening in the US is cost-effective.
Andrawiss
Mariam
M
D003362:Cost-Benefit Analysis; D015658:HIV Infections / Q000191:economics / Q000453:epidemiology*; D015497:HIV-1; D006801:Humans; D008403:Mass Screening / Q000191:economics* / Q000941:ethics; D014481:United States